COVID-19mRNA

Na-Na Zhang1, Xiao-Feng Li2, Yong-Qiang Deng2

  • 1State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China; School of Medicine, Tsinghua University, Beijing 100084, China.

Cell
|August 16, 2020
PubMed
概括

一种新型的脂质纳米粒子封装信使RNA (mRNA) 疫苗ARCoV针对SARS-CoV-2受体结合域,在临床前模型中显示出强大的中和抗体和完整的保护. 这种COVID-19候选疫苗具有室温稳定性.